Effects of β-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: An in vivo and in vitro study

Journal of Neuroimmunology

Volumn 79, Issue 1, 1997, Pages 76-83

  Corsini, E ^a   Gelati, M ^a   Dufour, A ^a   Massa, G ^a   Nespolo, A ^a   Ciusani, E ^a   Milanese, C ^a   La Mantia, L ^a   Salmaggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

IFN 1b; Adhesion; HUVECs; MS human cerebral endothelium; Multiple sclerosis; SVCAM 1

Indexed keywords

BETA1 INTEGRIN; CD18 ANTIGEN; CELL ADHESION MOLECULE; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BRAIN; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UMBILICAL VEIN;

ADULT; ANTIGENS; CELL ADHESION; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030680316     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00114-8     Document Type: Article

References (38)

1. Archelos J.J., Jung S., Maurer M., Schmied M., Lassmann H., Tamatani T., Miyasaka M., Toyka K.V., Hartung H.P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
2. Barna B.P., Chou S.M., Jacobs B., Yen-Lieberman B., Ransohoff R.M. Interferon beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 23:1989;45-53.
3. Benschop R.J., De Smet M.B.M., Bloem A.C., Ballieux R.E. Adhesion of subsets of human blood mononuclear cells to endothelial cells in vitro, as quantified by flow cytomerty. Scand. J. Immunol. 36:1992;793-800.
4. Brod S.A., Marshall G.D., Henninger E.M., Sriram S., Khan M., Wolinsky J.S. Interferon β-1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology. 46:1996;1633-1637.
5. Dhib-Jalbut S., Jiang H., Williams G.J. The effect of Interferon-β-1b on lymhocyte-endothelial cell adhesion. J. Neuroimmunol. 71:1996;215-222.
6. Dore-Duffy P., Newman W., Balabanov R., Lisak R.P., Mainolfi E., Rothlein R., Petrson M. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: Correlation with clinical activity. Ann. Neurol. 37:1995;55-62.
7. Dufour, A., Corsini, E., Gelati, M., Ciusani, E., Zaffaroni, M., Giombini, S., Massa, G., Milanese, C., Nespolo, A., Salmaggi, A. Modulation of HLA-DR, ICAM-1 and VCAM-1 on human brain endothelial cells: Effects of cytokines and dexamethazone, submitted.
8. Droogan A.G., McMillan S.A., Douglas J.P., Hawkins S.A. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: Predominant intrathecal release of vascular cell adhesion molecule-1. J. Neuroimmunol. 64:1996;185-191.
9. Gearing, A.J.H., Hemingway, I., Pigott, R., Hughes, E.J., Rees, A.J., Cashman, S.J. (1990), Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann. NY Acad. Sci. 667, 324-331.
10. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 10:1993;506-512.
11. Hall G.L., Wing M.G., Compston D.A.S., Scolding N.J. β-interferon regulates the immunomodulatory activity of neonatal rodent microglia. J. Neuroimmunol. 72:1997;11-19.
12. Hartung H.P., Michels M., Reiners K., Seeldrayers P., Archelos J.J., Toyka K.V. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology. 43:1993;2331-2335.
13. Huynh H.K., Oger J., Dorovini-Zis K. Interferon-β downregulates interferon-γ-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells. J. Neuroimmunol. 60:1995;63-73.
14. Inaba K., Kitaura M., Kato T., Watanabe Y., Kawade Y., Muramatsu S. Contrasting effect of alpha/beta and gamma interferons on expression of macrophage Ia Ags. J. Exp. Med. 163:1986;1030-1035.
15. Isaacs A., Lindennmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. 147:1957;258-267.
16. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:1973;2745-2756.
17. Jiang H., Milo R., Swoveland P., Johnson K.P., Panitch H., Dhib-Jalbut S. Interferon β 1b reduces interferon γ-induced antigen-presenting capacity of human glial and B cells. J. Neuroimmunol. 61:1995;17-25.
18. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: An expanded disability scale (EDSS). Neurology. 33:1983;1444-1445.
19. Ling P.D., Warren M.K., Vogel S.N. Antagonistic effect of IFN-β on the IFN-γ-induced expression of Ia Ag in murine macrophages. J. Immunol. 135:1985;1857-1863.
20. Miller A., Lanir N., Shapiro S., Revel M., Honigman S., Kinarty A., Lahat N. Immunoregolatory effects of interferon-β and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis and other autoimmune diseases. J. Neuroimmunol. 64:1996;151-161.
21. Mrsulia B.B., Mrsulia B.T., Fujimoto T., Klatzo I., Spatz M. Isolation of brain capillaries: A simplified technique. Brain Res. 110:1976;361-365.
22. Panitch H.S., Folus J.S., Johnson K. Recombinant beta interferon inhibits gamma interferon production in multiple sclerosis (abstract). Ann. Neurol. 22:1987;139.
23. Panitch H., Hirsch R., Schindler J., Johnson K. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
24. Paty, D.W., Li, D.K.B., The UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter randomized, double-blind, placebo-controlled trial. Neurology 43, 662-667.
25. Pigott R., Dillon L.P., Hemingway I.K., Gearing A.J.H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187:1992;584-589.
26. Porrini A.M., Gambi D., Reder A.T. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J. Neuroimmunol. 61:1995;27-34.
27. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
28. Raine C.S., Lee S.C., Scheinberg L.C.et al. Adhesion molecules in endothelial cells in the cental nervous system: An emerging area in neuroimmunology of multiple sclerosis. Clin. Immunol. Immunopathol. 57:1990;173-187.
29. Rieckmann P., Michel U., Albrecht M., Bruck W., Wockel L., Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60:1995;9-15.
30. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
31. Rudick R.A., Ransohoff R.M., Peppler R., VanderBrug-Medendorp S., Lehmann P., Alam J. Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis. Ann. Neurol. 40(4):1996;618-627.
32. Seth R., Raymond F., Makgoba M. Circulating ICAM-1 isoforms: Diagnostic prospects for inflammatory and immune disorders. Lancet. 338:1991;83-84.
33. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 43:1993;15-21.
34. Soilu-Hanninen M., Salmi A., Salonen R. Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes. J. Neuroimmunol. 60:1995;99-106.
35. Stuve O., Dooley N.P., Hum J.H., Antel J.P., Francis G.S., Williams G., Yong V.W. Interferon-β1-b decreases the migration of T-lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann. Neurol. 40:1996;853-863.
36. IFNB Multiple Sclerosis Study Group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:1993;655-661.
37. IFNB Multiple Sclerosis Study Group and University of British Columbia MS/MRI Analysis Group Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology. 45:1995;1277-1285.
38. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature. 356:1992;63-66.